|
|
|
By Kishore Hotha, Ph.D., Dr. Hotha’s Life Sciences LLC | The warning letter, issued to Purolea Cosmetics Lab, describes a manufacturer that used AI agents to generate drug product specifications and more. Here's why the outsourced pharma industry should take note. | |
|
|
|
|
| The Challenges Of Moving A Bioconjugate From Clinic To Market | Article | By Iwan Bertholjotti and Dr. Bernhard Stump, Lonza | Working with a partner that provides a one-stop shop for bioconjugate development and manufacturing helps prevent missteps that threaten the delivery of life-saving drugs to patients who need them. |
|
|
|
|
| Safely Scaling High Potency API Manufacturing | White Paper | Recipharm AB | Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up. |
|
|
|
|
| How To Choose The Right CDMO Partner For Fill And Finish | Article | medac CDMO | CDMO selection requires evaluating experience, quality standards, and flexibility. Assess technical transfer skills, supply chain security, and collaborative approach for a reliable, long-term project fit. |
|
|
| Application Of Plant And Process Models | White Paper | Boehringer Ingelheim Biopharmaceuticals GmbH | Gain insight into innovative process and facility models that optimize efficiency, sustainability, and cost-effectiveness in biopharmaceutical manufacturing. |
|
|
|
|
|
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|